{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:29:46Z","timestamp":1781155786518,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T00:00:00Z","timestamp":1503964800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s40266-017-0487-1","type":"journal-article","created":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T06:03:36Z","timestamp":1503986616000},"page":"767-776","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Discontinuation of Preventive Medicines in Older People with Limited Life Expectancy: A Systematic Review"],"prefix":"10.1007","volume":"34","author":[{"given":"Sujita W.","family":"Narayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad S.","family":"Nishtala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,29]]},"reference":[{"key":"487_CR1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.archger.2015.10.007","volume":"62","author":"SW Narayan","year":"2016","unstructured":"Narayan SW, Tordoff JM, Nishtala PS. Temporal trends in the utilisation of preventive medicines by older people: a 9-year population-based study. Arch Gerontol Geriatr. 2016;62:103\u201311.","journal-title":"Arch Gerontol Geriatr"},{"key":"487_CR2","doi-asserted-by":"crossref","unstructured":"McNeil MJ, Kamal AH, Kutner JS, Ritchie CS, Abernethy AP. The Burden of polypharmacy in patients near the end of life. J Pain Symptom Manage. 2016;51(2):178\u201383.e2.","DOI":"10.1016\/j.jpainsymman.2015.09.003"},{"issue":"7","key":"487_CR3","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/pds.3624","volume":"23","author":"PS Nishtala","year":"2014","unstructured":"Nishtala PS, Narayan SW, Wang T, Hilmer SN. Associations of drug burden index with falls, general practitioner visits, and mortality in older people. Pharmacoepidemiol Drug Saf. 2014;23(7):753\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"487_CR4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40801-015-0020-y","volume":"2","author":"SW Narayan","year":"2015","unstructured":"Narayan SW, Nishtala PS. Associations of potentially inappropriate medicine use with fall-related hospitalisations and primary care visits in older New Zealanders: a population-level study using the updated 2012 Beers Criteria. Drugs Real World Outcomes. 2015;2(2):137\u201341.","journal-title":"Drugs Real World Outcomes."},{"issue":"2","key":"487_CR5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/bmjspcare-2015-000941","volume":"7","author":"A Todd","year":"2017","unstructured":"Todd A, Husband A, Andrew I, et al. Inappropriate prescribing of preventative medication in patients with life-limiting illness: a systematic review. BMJ Support Palliat Care. 2017;7(2):113\u201321.","journal-title":"BMJ Support Palliat Care."},{"issue":"2","key":"487_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/jcpt.12487","volume":"42","author":"SW Narayan","year":"2017","unstructured":"Narayan SW, Nishtala PS. Decade-long temporal trends in the utilization of preventive medicines by centenarians. J Clin Pharm Ther. 2017;42(2):165\u20139. doi: 10.1111\/jcpt.12487 (Epub 2016 Dec 10).","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"487_CR7","first-page":"379","volume":"3","author":"P Kakar","year":"2012","unstructured":"Kakar P. Preventive medicine in the older patient: a United Kingdom perspective. Int J Prev Med. 2012;3(6):379\u201385.","journal-title":"Int J Prev Med."},{"issue":"21","key":"487_CR8","first-page":"2404","volume":"166","author":"DC Currow","year":"2006","unstructured":"Currow DC, Abernethy AP. Frameworks for approaching prescribing at the end of life. Arch Intern Med. 2006;166(21):2404.","journal-title":"Arch Intern Med"},{"issue":"10","key":"487_CR9","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1111\/j.1532-5415.2008.01916.x","volume":"56","author":"KT Bain","year":"2008","unstructured":"Bain KT, Holmes HM, Beers MH, et al. Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc. 2008;56(10):1946\u201352.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"487_CR10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/11536760-000000000-00000","volume":"27","author":"C Parsons","year":"2010","unstructured":"Parsons C, Hughes CM, Passmore AP, Lapane KL. Withholding, discontinuing and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying? Drugs Aging. 2010;27(6):435\u201349.","journal-title":"Drugs Aging"},{"issue":"5","key":"487_CR11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamainternmed.2015.0289","volume":"175","author":"JS Kutner","year":"2015","unstructured":"Kutner JS, Blatchford PJ, Taylor DH Jr, et al. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. JAMA Intern Med. 2015;175(5):691\u2013700.","journal-title":"JAMA Intern Med."},{"issue":"4","key":"487_CR12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1089\/jpm.2012.0158","volume":"16","author":"EA Bayliss","year":"2013","unstructured":"Bayliss EA, Bronsert MR, Reifler LM, et al. Statin prescribing patterns in a cohort of cancer patients with poor prognosis. J Palliat Med. 2013;16(4):412\u20138.","journal-title":"J Palliat Med."},{"issue":"6","key":"487_CR13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00520-008-0541-y","volume":"17","author":"RP Riechelmann","year":"2009","unstructured":"Riechelmann RP, Krzyzanowska MK, Zimmermann C. Futile medication use in terminally ill cancer patients. Support Care Cancer. 2009;17(6):745\u20138.","journal-title":"Support Care Cancer"},{"issue":"3","key":"487_CR14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/ijcp.12780","volume":"70","author":"NJ Ailabouni","year":"2016","unstructured":"Ailabouni NJ, Nishtala PS, Mangin D, Tordoff JM. General practitioners\u2019 insight into deprescribing for the multimorbid older individual: a qualitative study. Int J Clin Pract. 2016;70(3):261\u201376.","journal-title":"Int J Clin Pract"},{"issue":"6","key":"487_CR15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/archinte.166.6.605","volume":"166","author":"HM Holmes","year":"2006","unstructured":"Holmes HM, Hayley DC, Alexander GC, Sachs GA. Reconsidering medication appropriateness for patients late in life. Arch Intern Med. 2006;166(6):605\u20139.","journal-title":"Arch Intern Med"},{"issue":"7471","key":"487_CR16","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/bmj.329.7471.909","volume":"329","author":"J Stevenson","year":"2004","unstructured":"Stevenson J, Abernethy AP, Miller C, Currow DC. Managing comorbidities in patients at the end of life. BMJ. 2004;329(7471):909\u201312.","journal-title":"BMJ"},{"key":"487_CR17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2296-13-56","volume":"13","author":"J Schuling","year":"2012","unstructured":"Schuling J, Gebben H, Veehof LJ, Haaijer-Ruskamp FM. Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study. BMC Fam Pract. 2012;13:56.","journal-title":"BMC Fam Pract."},{"issue":"3","key":"487_CR18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s11096-014-9932-y","volume":"36","author":"A Todd","year":"2014","unstructured":"Todd A, Nazar H, Pearson S, et al. Inappropriate prescribing in patients accessing specialist palliative day care services. Int J Clin Pharm. 2014;36(3):535\u201343.","journal-title":"Int J Clin Pharm."},{"key":"487_CR19","unstructured":"The New Zealand Formulary. http:\/\/nzformulary.org\/ . Accessed 22 July 2016."},{"key":"487_CR20","unstructured":"The Cochrane Collaboration\u2019s tool for assessing risk of bias. London: Cochrane Collaboration. http:\/\/handbook.cochrane.org\/chapter_8\/8_5_the_cochrane_collaborations_tool_for_assessing_risk_of_bias.htm . Accessed 24 Mar 2017."},{"key":"487_CR21","unstructured":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp . Accessed 24 Mar 2017."},{"key":"487_CR22","unstructured":"STROBE Statement. https:\/\/www.strobe-statement.org\/index.php?id=strobe-home . Accessed 24 Mar 2017."},{"key":"487_CR23","doi-asserted-by":"crossref","first-page":"g1687","DOI":"10.1136\/bmj.g1687","volume":"348","author":"TC Hoffmann","year":"2014","unstructured":"Hoffmann TC, Glasziou PP, Boutron I, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687.","journal-title":"BMJ"},{"issue":"11","key":"487_CR24","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1111\/jgs.13105","volume":"62","author":"J Tjia","year":"2014","unstructured":"Tjia J, Cutrona SL, Peterson D, et al. Statin discontinuation in nursing home residents with advanced dementia. J Am Geriatr Soc. 2014;62(11):2095\u2013101.","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"487_CR25","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/jth.13427","volume":"14","author":"G Bertozzo","year":"2016","unstructured":"Bertozzo G, Zoppellaro G, Granziera S, et al. Reasons for and consequences of vitamin K antagonist discontinuation in very elderly patients with non-valvular atrial fibrillation. J Thromb Haemost. 2016;14(11):2124\u201331.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"487_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2012-000880","volume":"2","author":"EP Stavrou","year":"2012","unstructured":"Stavrou EP, Buckley N, Olivier J, Pearson SA. Discontinuation of statin therapy in older people: does a cancer diagnosis make a difference? An observational cohort study using data linkage. BMJ Open. 2012;2(3):1\u20136.","journal-title":"BMJ Open."},{"issue":"4","key":"487_CR27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/082585970602200405","volume":"22","author":"T Tanvetyanon","year":"2006","unstructured":"Tanvetyanon T, Choudhury AM. Physician practice in the discontinuation of statins among patients with advanced lung cancer. J Palliat Care. 2006;22(4):281\u20135.","journal-title":"J Palliat Care"},{"issue":"4","key":"487_CR28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/imj.13024","volume":"46","author":"PS Nishtala","year":"2016","unstructured":"Nishtala PS, Gnjidic D, Chyou T, Hilmer SN. Discontinuation of statins in a population of older New Zealanders with limited life expectancy. Intern Med J. 2016;46(4):493\u20136.","journal-title":"Intern Med J."},{"issue":"5","key":"487_CR29","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1089\/jpm.2007.0215","volume":"11","author":"MJ Silveira","year":"2008","unstructured":"Silveira MJ, Kazanis AS, Shevrin MP. Statins in the last six months of life: a recognizable, life-limiting condition does not decrease their use. J Palliat Med. 2008;11(5):685\u201393.","journal-title":"J Palliat Med."},{"issue":"4","key":"487_CR30","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1532-5415.2007.01124.x","volume":"55","author":"DC Currow","year":"2007","unstructured":"Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM. Prescribing in palliative care as death approaches. J Am Geriatr Soc. 2007;55(4):590\u20135.","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"487_CR31","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s40266-013-0095-7","volume":"30","author":"HM Holmes","year":"2013","unstructured":"Holmes HM, Min LC, Yee M, et al. Rationalizing prescribing for older patients with multimorbidity: considering time to benefit. Drugs Aging. 2013;30(9):655\u201366.","journal-title":"Drugs Aging"},{"issue":"5","key":"487_CR32","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jamainternmed.2015.0328","volume":"175","author":"HM Holmes","year":"2015","unstructured":"Holmes HM, Todd A. Evidence-based deprescribing of statins in patients with advanced illness. JAMA Intern Med. 2015;175(5):701\u20132.","journal-title":"JAMA Intern Med."},{"key":"487_CR33","doi-asserted-by":"publisher","unstructured":"Poudel A, Yates P, Rowett D, Nissen LM. Use of preventive medication in patients with limited life expectancy: a systematic review. J Pain Symptom Manage. 2017;53(6):1097\u20131110.e1. doi: 10.1016\/j.jpainsymman.2016.12.350 (Epub 2017 Feb 9).","DOI":"10.1016\/j.jpainsymman.2016.12.350"},{"issue":"2","key":"487_CR34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/bmjspcare-2015-000941","volume":"7","author":"A Todd","year":"2017","unstructured":"Todd A, Husband A, Andrew I, et al. Inappropriate prescribing of preventative medication in patients with life-limiting illness: a systematic review. BMJ Support Palliat Care. 2017;7(2):113\u201321. doi: 10.1136\/bmjspcare-2015-000941 (Epub 2016 Jan 5).","journal-title":"BMJ Support Palliat Care."},{"issue":"24","key":"487_CR35","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1001\/jama.2013.282612","volume":"310","author":"SJ Lee","year":"2013","unstructured":"Lee SJ, Leipzig RM, Walter LC. Incorporating lag time to benefit into prevention decisions for older adults. JAMA. 2013;310(24):2609\u201310.","journal-title":"JAMA"},{"issue":"4","key":"487_CR36","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","volume":"60","author":"American Geriatrics Society Beers Criteria Update Expert Panel","year":"2012","unstructured":"American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616\u201331.","journal-title":"J Am Geriatr Soc"},{"issue":"Suppl 2","key":"487_CR37","doi-asserted-by":"crossref","first-page":"S373","DOI":"10.1111\/j.1532-5415.2007.01345.x","volume":"55","author":"WH Shrank","year":"2007","unstructured":"Shrank WH, Polinski JM, Avorn J. Quality indicators for medication use in vulnerable elders. J Am Geriatr Soc. 2007;55(Suppl 2):S373\u201382.","journal-title":"J Am Geriatr Soc"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-017-0487-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-017-0487-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-017-0487-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T17:52:11Z","timestamp":1570038731000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-017-0487-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,29]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["487"],"URL":"https:\/\/doi.org\/10.1007\/s40266-017-0487-1","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,29]]}}}